System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Meta-Analysis Systematic Review Ppublish 8 citations

PubMed: 33218672 DOI: 10.1016/j.bja.2020.09.048

Reducing the dose of neuromuscular blocking agents with adjuncts: a systematic review and meta-analysis.

Br J Anaesth 126(3):608-621

Authors: Valentin Weber, Tom E F Abbott, Gareth L Ackland

Affiliations

  • Queen Mary University of London, Barts and the London School of Medicine and Dentistry, London, UK.
  • Queen Mary University of London, Barts and the London School of Medicine and Dentistry, London, UK; William Harvey Research Institute, Queen Mary University of London, London, UK.
  • Queen Mary University of London, Barts and the London School of Medicine and Dentistry, London, UK; William Harvey Research Institute, Queen Mary University of London, London, UK.

Abstract

BACKGROUND

Acute global shortages of neuromuscular blocking agents (NMBA) threaten to impact adversely on perioperative and critical care. The use of pharmacological adjuncts may reduce NMBA dose. However, the magnitude of any putative effects remains unclear.

METHODS

We conducted a systematic review and meta-analysis of RCTs. We searched Medline, Embase, Web of Science, and Cochrane Database (1970-2020) for RCTs comparing use of pharmacological adjuncts for NMBAs. We excluded RCTs not reporting perioperative NMBA dose. The primary outcome was total NMBA dose used to achieve a clinically acceptable depth of neuromuscular block. We assessed the quality of evidence using the GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) criteria. Data are presented as the standardised mean difference (SMD); I 2 indicates percentage of variance attributable to heterogeneity.

RESULTS

From 3082 records, the full texts of 159 trials were retrieved. Thirty-one perioperative RCTs met the inclusion criteria for meta-analysis (n=1962). No studies were conducted in critically ill patients. Reduction in NMBA dose was associated with use of magnesium (SMD: -1.10 [-1.44 to -0.76], P<0.001; I 2=85%; GRADE=moderate), dexmedetomidine (SMD: -0.89 [-1.55 to -0.22]; P=0.009; I 2=87%; GRADE=low), and clonidine (SMD: -0.67 [-1.13 to -0.22]; P=0.004; I 2=0%; GRADE=low) but not lidocaine (SMD: -0.46 [-1.01 to -0.09]; P=0.10; I 2=68%; GRADE=moderate). Meta-analyses for nicardipine, diltiazem, and dexamethasone were not possible owing to the low numbers of studies. We estimated that 30-50 mg kg -1 magnesium preoperatively (8-15 mg kg h -1 intraoperatively) reduces rocuronium dose by 25.5% (inter-quartile range, 14.7-31).

CONCLUSIONS

Magnesium, dexmedetomidine, and clonidine may confer a clinically relevant sparing effect on the required dose of neuromuscular block ing drugs in the perioperative setting.

SYSTEMATIC REVIEW REGISTRATION

PROSPERO: CRD42020183969.

MeSH

Calcium Channel Blockers, Lidocaine, Neuromuscular Blocking Agents, Dexmedetomidine, Clonidine, Neuromuscular Blockade, Dexamethasone, Anesthesiology

Cited by